Earlier today (Dec. 4th), the Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs (MOEA) opened its pavilion at the "2025 Healthcare+ Expo Taiwan" and presented 15 cutting-edge medical technology achievements, including smart medical devices, precision testing, regenerative repair and process innovation, with Metal Industries Research & Development Centre (MIRDC), Industrial Technology Research Institute (ITRI) and Development Center for Biotechnology (DCB). These outcomes demonstrate that Taiwan has the capability to conduct independent research and development, as well as the capability to commercialize smart healthcare core technologies and clinical applications. DoIT also witnessed the signing of an agreement between the MIRDC and Formosa Heavy Industries for the technology licensing of the "Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment System," which signifies that a domestically developed key technology for rTMS has officially moved towards commercial application.

At the opening ceremony of the pavilion, Kuo Chao-Chung, the Director General of DoIT, pointed out that the turnover of Taiwan's biomedicine industry reached NT$775.4 billion in 2024, with the medical device industry contributing NT$210 billion. The sales of digital medical devices have an annual growth rate of over 10%. In other words, technology has been integrated into healthcare, and Taiwan has incorporated sensing technology and artificial intelligence into medical devices, enabling the ICT and biomedicine industries to continue expanding. DoIT also puts together corporate R&D capabilities and industrial resources to ensure that medical technology moves from the laboratory to clinical application and mass production to demonstrate Taiwan's strengths in linking and application of smart medical technologies.

This year's pavilion features a one-stop supply chain for the "Optically Pumped Magnetoencephalography Diagnostic and Multi-channel Transcranial Magnetic Stimulation (rTMS) System," a system developed in Taiwan with great potential for export and OEM. This system integrates a highly sensitive optical magnetic sensing chip and AI algorithms to help doctors assess brain function in real-time, shortening treatment time by approximately 30%. It can be used to support the treatment of neurological and psychiatric disorders such as depression and obsessive-compulsive disorder. The technology has won the Gold Award at the 2025 Edison Awards, a prestigious award recognized as a global indicator of technological innovation. At the same time, the pavilion also showcases the world's first "Wearable digital diary and motion guide for Parkinsonism," which improves "frozen gait" through leg electrical stimulation, helping Parkinson's patients regain their ability to walk. The next-generation sterilization and purification technologies, "Low-temperature plasma sterilization technology, NO2 gas sterilization technology, and tangential flow filtration (TFF) technology, can effectively replace traditional high-temperature or EO sterilization methods with higher toxicity risks.

Apart from the highlights, the pavilion showcases a total of 15 exhibits, including a solution for sleep apnea, a surface imaging device for real-time mapping of cardiovascular and lymphatic circulation, an intranasal optical coherence tomography system, and innovative applications of a self-amplifying mRNA technology platform for infectious diseases. These showcase DoIT's R&D capabilities from diagnosis and treatment to total care, making DoIT a smart partner for medical applications and guardian of the health of Taiwanese people.